{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:15Z","timestamp":1792099695860,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173365"],"award-info":[{"award-number":["82173365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672810"],"award-info":[{"award-number":["81672810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JZ-36"],"award-info":[{"award-number":["2021JZ-36"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017620","name":"Shaanxi Science and Technology Co-ordination and Innovation Project of China","doi-asserted-by":"publisher","award":["2020JM-362"],"award-info":[{"award-number":["2020JM-362"]}],"id":[{"id":"10.13039\/501100017620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["2020QN-05"],"award-info":[{"award-number":["2020QN-05"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["2019ZYTS-19"],"award-info":[{"award-number":["2019ZYTS-19"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tranon.2024.102193","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T21:41:53Z","timestamp":1732138913000},"page":"102193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review"],"prefix":"10.1016","volume":"51","author":[{"given":"Yaochun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhuo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7624-478X","authenticated-orcid":false,"given":"Shuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0001","article-title":"Hippel-Lindau disease: Updated guideline for diagnosis and surveillance","volume":"65","author":"Louise","year":"2022","journal-title":"Eur. J. Med. Genet."},{"issue":"18","key":"10.1016\/j.tranon.2024.102193_bib0002","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162480","article-title":"Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer","volume":"132","author":"Kaelin","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOU.0000000000000950","article-title":"OSR VHL Program. Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action","volume":"32","author":"Larcher","year":"2022","journal-title":"Curr. Opin. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2024.102193_bib0004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.hoc.2023.04.011","article-title":"von-Hippel Lindau and hypoxia-inducible factor at the center of renal cell carcinoma biology","volume":"37","author":"Shirole","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.tranon.2024.102193_bib0005","first-page":"21","article-title":"Challenges in Von Hippel-Lindau's disease: PRRT in patients on hemodialysis","volume":"2022","author":"Ayub","year":"2022","journal-title":"Endocrinol. Diabetes. Metab. Case Rep."},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0006","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/hmg\/ddad039","article-title":"Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan","volume":"32","author":"Tamura","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0008","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","article-title":"Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity","volume":"18","author":"Blankenship","year":"1999","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.tranon.2024.102193_bib0009","doi-asserted-by":"crossref","first-page":"14075","DOI":"10.3390\/ijms241814075","article-title":"VHL L169P variant does not alter cellular hypoxia tension in clear cell renal cell carcinoma","volume":"24","author":"Hu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10-12","key":"10.1016\/j.tranon.2024.102193_bib0010","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00726-019-02781-8","article-title":"Insights into the molecular features of the von Hippel-Lindau-like protein","volume":"51","author":"Minervini","year":"2019","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0011","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.3390\/ijms24043880","article-title":"Role of SOCS and VHL proteins in neuronal differentiation and development","volume":"24","author":"Kanno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.tranon.2024.102193_bib0012","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s42255-022-00593-x","article-title":"Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome","volume":"4","author":"Li","year":"2022","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.tranon.2024.102193_bib0013","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/genes13020362","article-title":"The role of VHL in the development of von Hippel-Lindau disease and erythrocytosis","volume":"13","author":"Hudler","year":"2022","journal-title":"Genes"},{"issue":"18","key":"10.1016\/j.tranon.2024.102193_bib0014","doi-asserted-by":"crossref","first-page":"12776","DOI":"10.1021\/acs.jmedchem.3c00434","article-title":"Expanding the structural diversity at the phenylene core of ligands for the von Hippel-Lindau E3 ubiquitin ligase: development of highly potent hypoxia-inducible factor-1\u03b1 stabilizers","volume":"66","author":"Vu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","article-title":"Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.tranon.2024.102193_bib0016","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41419-022-05008-z","article-title":"OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1\u03b1 during hypoxia adaptation","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2024.102193_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.586857","article-title":"The VHL\/HIF axis in the development and treatment of pheochromocytoma\/paraganglioma","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0018","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/cancers16030601","article-title":"Novel approaches with HIF-2\u03b1 targeted therapies in metastatic renal cell carcinoma","volume":"16","author":"Nguyen","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0019","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/cancers15041316","article-title":"Downstream targets of VHL\/HIF-\u03b1 signaling in renal clear cell carcinoma progression: mechanisms and therapeutic relevance","volume":"15","author":"Mazumder","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.tranon.2024.102193_bib0020","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1097\/01.ASN.0000092803.69761.41","article-title":"The von Hippel-Lindau gene, kidney cancer, and oxygen sensing","volume":"14","author":"Kaelin","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tranon.2024.102193_bib0021","article-title":"A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-019-0752-z","article-title":"HIF inhibitors: status of current clinical development","volume":"21","author":"Fallah","year":"2019","journal-title":"Curr. Oncol. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2024.102193_bib0023","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/carcin\/bgn275","article-title":"von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR","volume":"30","author":"Danilin","year":"2009","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.tranon.2024.102193_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13238-018-0586-8","article-title":"Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch","volume":"10","author":"Aki","year":"2019","journal-title":"Protein Cell"},{"issue":"5","key":"10.1016\/j.tranon.2024.102193_bib0026","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/cancers14051265","article-title":"Understanding retinoblastoma post-translational regulation for the design of targeted cancer therapies","volume":"14","author":"Janostiak","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0027","doi-asserted-by":"crossref","first-page":"F906","DOI":"10.1152\/ajprenal.00178.2017","article-title":"HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells","volume":"313","author":"Zhang","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.tranon.2024.102193_bib0028","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3892\/etm.2024.12516","article-title":"Upregulated expression of glucose transporter isoform 1 in invasive and metastatic extramammary Paget's disease","volume":"27","author":"Matsumoto","year":"2024","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.tranon.2024.102193_bib0029","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10585-023-10224-8","article-title":"Travelling under pressure - hypoxia and shear stress in the metastatic journey","volume":"40","author":"Ildiz","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.tranon.2024.102193_bib0030","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1038\/ncomms15337","article-title":"VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2","volume":"8","author":"Gao","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0031","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.7150\/ijbs.70742","article-title":"TBK1 Facilitates GLUT1-dependent glucose consumption by suppressing mtorc1 signaling in colorectal cancer progression","volume":"18","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"7916","key":"10.1016\/j.tranon.2024.102193_bib0032","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41586-022-04809-8","article-title":"The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer","volume":"606","author":"Patel","year":"2022","journal-title":"Nature"},{"issue":"613","key":"10.1016\/j.tranon.2024.102193_bib0033","doi-asserted-by":"crossref","first-page":"eabj1578","DOI":"10.1126\/scitranslmed.abj1578","article-title":"A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models","volume":"13","author":"Yu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"29","key":"10.1016\/j.tranon.2024.102193_bib0034","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1038\/s41388-022-02378-8","article-title":"The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation","volume":"41","author":"Strocchi","year":"2022","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.tranon.2024.102193_bib0035","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.7150\/jca.54163","article-title":"Inhibition of p22phox suppresses epithelial ovarian cancer cell proliferation and tumorigenesis","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2024.102193_bib0036","article-title":"Targeting Myc interacting proteins as a winding path in cancer therapy","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0037","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0038","doi-asserted-by":"crossref","first-page":"14827","DOI":"10.1038\/s41598-021-94132-5","article-title":"Neumann-Haefelin E. VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma","volume":"11","author":"Ganner","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.tranon.2024.102193_bib0039","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41419-023-05588-4","article-title":"VHL-HIF-2\u03b1 axis-induced SEMA6A upregulation stabilized \u03b2-catenin to drive clear cell renal cell carcinoma progression","volume":"14","author":"Ji","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0040","doi-asserted-by":"crossref","first-page":"e92193","DOI":"10.1172\/jci.insight.92193","article-title":"Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch","volume":"3","author":"Arreola","year":"2018","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.tranon.2024.102193_bib0041","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.3390\/cancers15184495","article-title":"Modern Kidney-Sparing management of upper tract urothelial carcinoma","volume":"15","author":"Ghoreifi","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0042","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13304-016-0400-1","article-title":"Parenchyma-sparing surgery for pancreatic endocrine tumors","volume":"68","author":"Uccelli","year":"2016","journal-title":"Updates. Surg."},{"key":"10.1016\/j.tranon.2024.102193_bib0043","first-page":"1","article-title":"Minimally invasive resection of spinal hemangioblastoma: feasibility and clinical results in a series of 18 patients","author":"Kr\u00fcger","year":"2019","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.tranon.2024.102193_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102497","article-title":"Surgical treatment for pelvic haemophilic pseudotumour: a retrospective analysis of 21 cases","volume":"69","author":"Bian","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-019-1517-0","article-title":"Targeting hypoxia in tumor: a new promising therapeutic strategy","volume":"39","author":"Bosco","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.tranon.2024.102193_bib0046","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2169\/internalmedicine.8701-21","article-title":"The first case of gastric neuroendocrine tumors induced by a proton pump inhibitor in von Hippel-Lindau disease","volume":"61","author":"Kawaguchi","year":"2022","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.tranon.2024.102193_bib0047","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.tranon.2024.102193_bib0048","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/15384047.2020.1769418","article-title":"Third-line sunitinib treatment in a VHL-mutated metastatic intrahepatic cholangiocarcinoma: a case report and literature review","volume":"21","author":"Li","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"20","key":"10.1016\/j.tranon.2024.102193_bib0049","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2217\/fon-2019-0021","article-title":"Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors","volume":"15","author":"Desai","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.tranon.2024.102193_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221108685","article-title":"Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review","volume":"14","author":"Lalani","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.tranon.2024.102193_bib0051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-031-36084-8_14","article-title":"VHL: trends and insight into a multi-modality, interdisciplinary approach for management of central nervous system hemangioblastoma","volume":"135","author":"Matloob","year":"2023","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.tranon.2024.102193_bib0052","article-title":"Central nervous system hemangioblastoma in a pediatric patient associated with von hippel-lindau disease: a case report and literature Review","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"issue":"22","key":"10.1016\/j.tranon.2024.102193_bib0053","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.tranon.2024.102193_bib0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11912-022-01354-5","article-title":"Belzutifan (MK-6482): biology and clinical development in solid tumors","volume":"25","author":"Choi","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.tranon.2024.102193_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/2589977514666220401094724","article-title":"Belzutifan: a narrative drug review","volume":"14","author":"Visweswaran","year":"2022","journal-title":"Curr. Drug Res. Rev."},{"issue":"5","key":"10.1016\/j.tranon.2024.102193_bib0056","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(23)00097-9","article-title":"Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study","volume":"24","author":"Choueiri","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2024.102193_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113906","article-title":"VHL-based PROTACs as potential therapeutic agents: recent progress and perspectives","volume":"227","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tranon.2024.102193_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116041","article-title":"Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders","volume":"265","author":"Setia","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200615","article-title":"Systematic potency and property Assessment of VHL ligands and implications on PROTAC design","volume":"18","author":"Krieger","year":"2023","journal-title":"ChemMedChem."},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ultrasmedbio.2020.11.001","article-title":"Ultrasound microbubble-mediated VHL regulates the biological behavior of ovarian cancer cells","volume":"47","author":"Li","year":"2021","journal-title":"Ultrasound. Med. Biol."},{"issue":"23","key":"10.1016\/j.tranon.2024.102193_bib0061","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.3390\/molecules27238457","article-title":"CD70-targeted micelles enhance HIF2\u03b1 siRNA delivery and inhibit oncogenic functions in patient-derived clear cell renal carcinoma cells","volume":"27","author":"Trac","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tranon.2024.102193_bib0062","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1479-5876-9-46","article-title":"Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma","volume":"9","author":"Xu","year":"2011","journal-title":"J. Transl. Med."},{"issue":"3-4","key":"10.1016\/j.tranon.2024.102193_bib0063","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41417-018-0041-2","article-title":"Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt\/\u03b2-catenin signaling","volume":"26","author":"Chen","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tranon.2024.102193_bib0064","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/crispr.2019.0018","article-title":"VHL synthetic lethality signatures uncovered by genotype-specific CRISPR-Cas9 screens","volume":"2","author":"Sun","year":"2019","journal-title":"CRISPR J."},{"key":"10.1016\/j.tranon.2024.102193_bib0065","doi-asserted-by":"crossref","first-page":"29032","DOI":"10.1038\/srep29032","article-title":"CRISPR-mediated VHL knockout generates an improved model for metastatic renal cell carcinoma","volume":"6","author":"Schokrpur","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2024.102193_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.598656","article-title":"Seven novel genes related to cell proliferation and migration of VHL-mutated pheochromocytoma","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tranon.2024.102193_bib0067","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1038\/ncomms15337","article-title":"VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2","volume":"8","author":"Gao","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0068","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11864-023-01161-5","article-title":"Treatment landscape of renal cell carcinoma","volume":"24","author":"Chen","year":"2023","journal-title":"Curr. Treat. Options. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0069","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","article-title":"Small molecules targeting the innate immune cGAS\u2012STING\u2012TBK1 signaling pathway","volume":"10","author":"Ding","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/CCO.0000000000000939","article-title":"Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma","volume":"35","author":"Goodstein","year":"2023","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0071","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15586\/jkcvhl.2020.135","article-title":"Resistance to pembrolizumab and axitinib in renal cell carcinoma: clinical and genomic evaluation","volume":"7","author":"Vlachostergios","year":"2020","journal-title":"J. Kidney Cancer VHL."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0072","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00281-018-0691-z","article-title":"Therapeutic cancer vaccine: building the future from lessons of the past","volume":"41","author":"Tran","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.tranon.2024.102193_bib0073","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/UA.UA_166_17","article-title":"New treatment modalities with vaccine therapy in renal cell carcinoma","volume":"11","author":"S\u00f6nmez","year":"2019","journal-title":"Urol. Ann."},{"issue":"11","key":"10.1016\/j.tranon.2024.102193_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278166","article-title":"Central nervous system hemangioblastomas in von Hippel-Lindau disease: total growth rate and risk of developing new lesions not associated with circulating VEGF levels","volume":"17","author":"Sundblom","year":"2022","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/neup.12625","article-title":"Formation of new lymphatic vessels in glioma: an immunohistochemical analysis","volume":"40","author":"Meng","year":"2020","journal-title":"Neuropathology."},{"key":"10.1016\/j.tranon.2024.102193_bib0076","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2017.11.002","article-title":"High speed flow cytometry allows the detection of circulating endothelial cells in hemangioblastoma patients","volume":"134-135","author":"De Biasi","year":"2018","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0077","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/cancers14010170","article-title":"Retinal glial cells in Von Hippel-Lindau disease: a novel approach in the pathophysiology of retinal hemangioblastoma","volume":"14","author":"Pilotto","year":"2021","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.tranon.2024.102193_bib0078","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.3390\/jcm11175196","article-title":"Immunohistochemical expression of CD44, MMP-2, MMP-9, and Ki-67 as the prognostic markers in non-clear cell renal cell carcinomas-a prospective cohort study","volume":"11","author":"Chraba\u0144ska","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0079","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/cren.2018.0032","article-title":"Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma","volume":"4","author":"Odom","year":"2018","journal-title":"J. Endourol. Case Rep."},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cancers11040586","article-title":"Chromogranin A in the laboratory diagnosis of pheochromocytoma and paraganglioma","volume":"11","author":"B\u00edlek","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0081","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3803\/EnM.2020.925","article-title":"Urinary free metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"36","author":"Ahn","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0082","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/endrev\/bnad006","article-title":"Advances in the treatment of gastroenteropancreatic neuroendocrine carcinomas: are we moving forward?","volume":"44","author":"Garcia-Carbonero","year":"2023","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.101601","article-title":"Chromogranin A and NSE in cystic pancreatic neuroendocrine tumors","volume":"45","author":"Faias","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.tranon.2024.102193_bib0084","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.3390\/cimb46040203","article-title":"Radiogenomics and texture analysis to detect von Hippel-Lindau (VHL) mutation in clear cell renal cell carcinoma","volume":"46","author":"Greco","year":"2024","journal-title":"curr Issues Mol Biol."},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0085","first-page":"46","article-title":"Selective HIF2A inhibitors in the management of clear cell renal cancer and Von Hippel-Lindau-disease-associated tumors","volume":"11","author":"Su\u00e1rez","year":"2023","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2024.102193_bib0086","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/diagnostics13010144","article-title":"Immunological aspects of Von Hippel-Lindau disease: a focus on neuro-oncology and myasthenia gravis","volume":"13","author":"Incorvaia","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.tranon.2024.102193_bib0087","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2024.102193_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1360942","article-title":"Von-Hipple Lindau syndrome with family history: a case report and seventeen years follow-up study","volume":"14","author":"Fan","year":"2024","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0089","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.3390\/cimb45120611","article-title":"Impact of hypoxia-induced miR-210 on pancreatic cancer","volume":"45","author":"Lian","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0090","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.3390\/curroncol29080429","article-title":"Next wave of targets in the treatment of advanced renal cell carcinoma","volume":"29","author":"Cardenas","year":"2022","journal-title":"Curr. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0091","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","article-title":"Management of retinal hemangioblastoma in Von Hippel-Lindau disease","volume":"39","author":"Wiley","year":"2019","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.tranon.2024.102193_bib0092","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","volume":"36","author":"Maher","year":"2018","journal-title":"World J. Urol."},{"issue":"3","key":"10.1016\/j.tranon.2024.102193_bib0093","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.33978","article-title":"Pancreatic Manifestations Recommendations Development Subcommittee of the VHL Alliance. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease","volume":"128","author":"Laks","year":"2022","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0094","article-title":"Hippel-Lindau disease: updated guideline for diagnosis and surveillance","volume":"65","author":"Louise","year":"2022","journal-title":"Eur. J. Med. Genet."},{"issue":"8","key":"10.1016\/j.tranon.2024.102193_bib0095","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00345-020-03574-5","volume":"39","author":"Capitanio","year":"2021","journal-title":"World J. Urol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332400319X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332400319X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:31:02Z","timestamp":1778833862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332400319X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":95,"alternative-id":["S193652332400319X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102193","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"102193"}}